Fedovapagon (VA106483) is a selective and orally active Vasotocin V2 receptor (V2R) agonist with an EC 50 of 24 nM. Fedovapagon can be used in the research of nocturiaIn VivoFedovapagon (1 mg/kg, oral administration) inhibits urine output with 81% inhibition rate in rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Brattleboro rats Dosage: 1 mg/kg, 3 mg/kg Administration: Oral administration Result: Reduced urine volume with almost full inhibition of urine output for 2 h. Returned the urine to normal levels 5 h after dosing.IC50& Target:V2 Receptor V2 Receptor 24 nM (EC 50 ). Specification: 10mM in DMSO Molecular Formula: C27H34N4O3 Molecular Weight: 462.58
- UPC:
- 51172339
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- F655342-1ml
- CAS:
- 347887-36-9
- Product Size:
- 1ml
